Prevalence and Treatment of Selective Mutism in Clinical Practice: A Survey of Child and Adolescent Psychiatrists

1994 ◽  
Vol 4 (4) ◽  
pp. 281-291 ◽  
Author(s):  
JOHN S. CARLSON ◽  
THOMAS R. KRATOCHWILL ◽  
HUGH JOHNSTON
2017 ◽  
Vol 41 (S1) ◽  
pp. 911-912
Author(s):  
Falissard B.

Psychiatrists, like most physicians, are fascinated by their classifications. Like art critics that distinguish surrealists, cubists, hyperrealists, minimalists, etc. psychiatrists try to reveal patterns of symptoms, emotions or behaviors from the patients they see in their day-to-day practice. But psychiatric disorders are not used and determined only by psychiatrists. As pointed by P. Zachar (2015), psychiatric disorders can be considered as biological dysfunction, patterns of symptoms helpful for treatment and prognosis, categories used by health insurances, categories used by judges, words used in the media, concepts used by sociologists (“The weariness of the self”, Alain Eherenberg).We will discuss in the conference what science can say about this confusion and what clinicians should consider for their clinical practice.Disclosure of interestThe author has not supplied his declaration of competing interest.


2003 ◽  
Vol 9 (2) ◽  
pp. 86-94 ◽  
Author(s):  
Dave Coghill

Drug treatments play an important role in the treatment of child and adolescent psychiatric disorders. However, there is often a long delay before research findings are translated into clinical practice; furthermore, changes in clinical practice outstrip the available evidence. This paper focuses on current issues and research findings on the pharmacological treatment of attention-deficit hyperactivity disorder (ADHD) and affective disorders. Clinical findings from a US study of the treatment of ADHD with extended-release stimulants and non-stimulants, and the development and use of clinical guidelines are discussed. Clinical trials of selective serotonin reuptake inhibitors for early-onset depression, approaches to managing treatment-resistant depression and guidance on the drug treatment of early-onset mania are considered.


Sign in / Sign up

Export Citation Format

Share Document